Quantcast

Latest genital herpes Stories

2010-03-23 06:02:00

BARRINGTON, Ill., March 23 /PRNewswire/ -- Merix Pharmaceutical Corp. unveiled its new Fast-Results!(TM) Genital Herpes Treatment March 1st while attending a retail industry trade show in Dallas. The first ever OTC treatment for genital herpes, Fast-Results! answers the unmet need of people who suffer painful symptoms caused by the herpes virus. Intended to be used in conjunction with prescription medication, Fast-Results! brings effective and affordable treatment to consumers who cannot...

2c589e0ea435c78542a0d4970c0d4e7f
2010-03-10 11:30:00

One out of every six Americans between the ages of 14 and 49 have been infected with genital herpes, the Centers for Disease Control and Prevention (CDC) announced on Tuesday, re-emphasizing the need for safe sexual practices. According to the CDC's National Health and Nutrition Examination Survey (NHANES), 11.5-percent of men and 21-percent of women have been infected with herpes simplex virus type 2 (HSV-2), the sexually transmitted virus which is the primary cause of herpes. Furthermore,...

2010-01-22 13:59:01

Genital herpes caused by a reactivation of herpes simplex virus type 2 (HSV-2) is generally treated as a lesion in one specific area of the genital region. A new study, however, finds that the virus can frequently reactivate throughout the genital tract, an important new concept that could help guide both HSV-2 treatment and prevention. Now available online, the study appears in the Feb. 15 issue of The Journal of Infectious Diseases. In the study, Christine Johnston, MD, MPH, and colleagues...

2010-01-20 18:15:25

A five-year international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment taken twice daily to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2. The results of the study are published in the New England Journal of Medicine online today, and will appear in the Feb. 4, 2010 issue of the...

2009-09-22 07:00:00

MELBOURNE, Australia, Sept. 22 /PRNewswire/ -- Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announced that it has received notification of the grant in the US of a key patent specifically relating to the use of SPL7013 to protect against sexually transmitted infections (STIs). The granting of this patent means that any product presentation of SPL7013 (the active ingredient in VivaGel(R) ) is now protected in the US for an additional five years until 2024, with a possible...

2009-08-02 12:55:00

New research helps explain why infection with herpes simplex virus-2 (HSV-2), which causes genital herpes, increases the risk for HIV infection even after successful treatment heals the genital skin sores and breaks that often result from HSV-2. Scientists have uncovered details of an immune-cell environment conducive to HIV infection that persists at the location of HSV-2 genital skin lesions long after they have been treated with oral doses of the drug acyclovir and have healed and the skin...

2009-07-14 16:30:22

Condom use is associated with a 30 percent reduced risk of contracting herpes simplex virus 2, also known as genital herpes, U.S. researchers said. Emily T. Martin of Children's Hospital Research Institute and the University of Washington in Seattle and colleagues analyzed data from six studies to assess the effectiveness of condom use in preventing genital herpes. The studies included 5,384 Herpes simplex virus 2-negative individuals -- average age 29 -- at baseline for a combined total of...

2009-05-08 10:24:20

Study demonstrates modest reduction in HIV disease progression, leads to new insights about HIV transmission A recently completed international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2. The majority of people with HIV infection also have...

2008-08-29 00:00:36

The alarming fact is that over half of all Americans have oral herpes and at least twenty percent (one out of five) suffer from genital herpes or herpes simplex 2 (HSV-2). Studies indicate that more than 500,000 new cases of genital herpes are diagnosed in the United States each year and an untold number go untreated. Combine these figures with the number of other sexually transmitted diseases (S.T.D.s), added to the number of urinary tract infections (U.T.I.s) contracted every year, and the...

2008-08-20 09:00:22

WOBURN, Mass., Aug. 20 /PRNewswire/ -- BioVex Inc, a biotechnology company developing clinical stage treatments for cancer and the prevention of infectious disease, today announced the UK Medicines and Healthcare products Regulatory Agency (MHRA) has accepted BioVex's Clinical Trial Application to conduct a Phase I clinical study testing the safety and immunogenicity of its lead infectious disease candidate for genital herpes, ImmunoVEX HSV2. ImmunoVEX HSV2 is a novel live-attenuated...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related